AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
On 17th June 2020, the equity market of Australia ended in green, and the S&P/ASX200 moved up by 49.5 points to 5991.8. The index has lost 2.55% and 8.25% during the last five days and the last 52-weeks, respectively. S&P/ASX 200 Health Care (Sector) closed at 41,925.1, reflecting an increase of 1.37%. S&P/ASX 200 Energy (Sector) stood at 7,734.4 with a rise of 79.7 points. All Ordinaries settled at 6109.1, indicating an increase of 51 points on an intraday basis.
On ASX, the stock of CLINUVEL Pharmaceuticals Limited (ASX: CUV) experienced a rise of 8.08% to $27.020 per share. The share price of carsales.com Limited (ASX: CAR) went up by 6.195% and ended the trading session at $18.000 per share.
CUV Performance (Source: ASX)
Coming to the New Zealand market, S&P/NZX50 witnessed a sharp rise of 3.47% to 11,334 at the end of the session. The stock of Pacific Edge Limited (NZX: PEB) soared by 79.39% to NZ$0.235 per share. The stock of Me Today Limited (NZX: MEE) mounted up by 35.45% to NZ$0.149 per share. On the other hand, Abano Healthcare Group Limited’s (NZX: ABA) share price slipped by 10.30% to NZ$2.960 per share.
Recently, we have penned some crucial information on Ardiden Limited (ASX:ADV), and the readers can view the article by clicking here.
CLINUVEL Pharmaceuticals Limited Rose 8.08% on the Australian Securities Exchange
CLINUVEL Pharmaceuticals Limited (ASX:CUV) stated that its business is profitable and cash flow positive in the current situation. The company’s objective revolves around the development and delivery of new products. CUV is evolving into a diversified and integrated pharmaceutical business, providing treatments to multiple patient groups. With respect to Europe, the company is working on the reimbursement agreements to (1) distribute SCENESSE® for EPP in more European countries, (2) expand the number of Expert Centers and (3) increase patient treatment access. Over the time, the company’s financial performance has experienced decent progress through the Research & Development Phase into the Commercial Phase.
carsales.com Limited Ended in Green on 17th June 2020
carsales.com Limited (ASX:CAR) has recently updated the market with a business update, wherein it stated that overall lead and traffic volumes have experienced continuous improvement as social distancing measures have been eased in Australia. Lead volumes have been strongly increased between 22 April 2020 and 16 June 2020. Over the last six weeks, total inventory on carsales.com.au has decreased, primarily due to a reduction in time to sell because of the increased demand from car buyers following the easing of social distancing restrictions. In another update, the company announced that David Wiadrowski had made a change to their holdings in the company on 5th June 2020 by acquiring 600 ordinary shares for the consideration of $9,876. The stock of carsales.com Limited is up by 6.195%, owing to the release of the business update and FY20 results estimate.
